Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Codeine prescribing practices before and after the 2017 FDA warning at an academic health system.

< BACK TO ARCHIVE


2022 Dec 10


J Am Pharm Assoc (2003)


http://www.ncbi.nlm.nih.gov/pubmed/36586748?dopt=Abstract

Codeine prescribing practices before and after the 2017 FDA warning at an academic health system.

Authors

Codeine prescribing practices before and after the 2017 FDA warning at an academic health system.
Vyhmeister K, Sierra CM
J Am Pharm Assoc (2003). 2022 Dec 10.
PMID: 36586748.

Abstract

In April of 2017, the U.S. Food and Drug Administration (FDA) issued a boxed warning contraindicating codeine use in all patients younger than 12 years of age.
Read This Paper